Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 1
1961 1
1963 1
1964 1
1965 1
1966 1
1976 1
1995 1
1998 1
2001 6
2003 5
2005 2
2006 5
2007 6
2008 5
2010 9
2011 9
2012 11
2013 6
2014 11
2015 8
2016 6
2017 8
2018 7
2019 8
2020 5
2021 5
2022 3
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group.
Constine LS, Yahalom J, Ng AK, Hodgson DC, Wirth A, Milgrom SA, Mikhaeel NG, Eich HT, Illidge T, Ricardi U, Dieckmann K, Moskowitz CH, Advani R, Mauch PM, Specht L, Hoppe RT. Constine LS, et al. Among authors: hodgson dc. Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1100-1118. doi: 10.1016/j.ijrobp.2018.01.011. Epub 2018 Jan 9. Int J Radiat Oncol Biol Phys. 2018. PMID: 29722655 Free article. Review.
Hodgkin's lymphoma.
Tsang RW, Hodgson DC, Crump M. Tsang RW, et al. Among authors: hodgson dc. Curr Probl Cancer. 2006 May-Jun;30(3):107-58. doi: 10.1016/j.currproblcancer.2006.04.001. Curr Probl Cancer. 2006. PMID: 16740424 Review. No abstract available.
ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma.
Dabaja BS, Advani R, Hodgson DC, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Younes A, Constine LS. Dabaja BS, et al. Among authors: hodgson dc. Am J Clin Oncol. 2015 Dec;38(6):610-20. doi: 10.1097/COC.0000000000000215. Am J Clin Oncol. 2015. PMID: 26583344 Review.
ACR Appropriateness Criteria: Localized nodal indolent lymphoma.
Hoppe BS, Hodgson DC, Advani R, Dabaja BS, Flowers CR, Ha CS, Metzger ML, Plastaras JP, Roberts KB, Shapiro R, Terezakis SA, Winkfield KM, Younes A, Constine LS. Hoppe BS, et al. Among authors: hodgson dc. Oncology (Williston Park). 2013 Aug;27(8):786-94. Oncology (Williston Park). 2013. PMID: 24133827 Review.
Comparative effectiveness of salvage chemotherapy regimens and chimeric antigen T-cell receptor therapies in relapsed and refractory diffuse large B cell lymphoma: a network meta-analysis of clinical trials.
Gong IY, Aminilari M, Landego I, Hueniken K, Zhou Q, Kuruvilla J, Hodgson DC. Gong IY, et al. Among authors: hodgson dc. Leuk Lymphoma. 2023 Oct;64(10):1643-1654. doi: 10.1080/10428194.2023.2234528. Epub 2023 Aug 7. Leuk Lymphoma. 2023. PMID: 37548344
ACR Appropriateness Criteria® Hodgkin Lymphoma-Unfavorable Clinical Stage I and II.
Roberts KB, Younes A, Hodgson DC, Advani R, Dabaja BS, Dhakal S, Flowers CR, Ha CS, Hoppe BS, Mendenhall NP, Metzger ML, Plastaras JP, Shapiro R, Smith SM, Terezakis SA, Winkfield KM, Constine LS; Expert Panel on Radiation OncologyLymphoma. Roberts KB, et al. Among authors: hodgson dc. Am J Clin Oncol. 2016 Aug;39(4):384-95. doi: 10.1097/COC.0000000000000294. Am J Clin Oncol. 2016. PMID: 27299425 Review.
132 results